Overall, biotechnology will continue to fuel a major transformation in healthcare—one that emphasizes earlier disease detection, more targeted
The current challenges that biotechs face include global issues, dramatically increasing drug development costs, and contentious regulatory
Thirty years after the first biotechnology company opened, the sector is reaching a new level of maturity and globalization.
Biotech Now Global
Thirty years after the first biotechnology company opened its doors, the sector is reaching a new level of maturity and globalization.
Biotechnology is driving a global transformation from the treatment of illness to the treatment of wellness; at the same time, the changing world is transforming biotechnology.
The biotech industry is no longer cent.
Biotech's Umbilical Cord—Capital
The biotech story is always about its capital market progress—a great year, a good year, or a lousy year—and good capital markets are the key to biotech's success.
Biotech's performance in the capital markets waxed and waned throughout 2006, at the mercy of prevailing macroeconomic forces, concern for Iraq, elections and politics, and healthcare co.
How has biotechnology evolved over the past 20 years?
Over the past 20 years, biotechnologies have evolved from intellectually intriguing biosciences into diversifying industries that produce useful biologicals from biocatalytic reactions, genetically modified bacteria, funghi, viruses, plant, mammalian and insect cells.
Partnering Predominates
For 30 years in the biotech business it has seemed, at least to outsiders, that the industry would be consumed by a wave of consolidations and mergers.
The specter that biotech will see extensive consolidation has been raised as cash-rich companies, from both pharmaceutical and biotech, seek opportunities to broaden pipelines with product candidate.
What are the future trends in Plant Biotechnology?
Also, having an insight into the roles of genes governing complex traits to actively improve agronomic performance or control adaptations to abiotic stresses is a matter of concern, as genetically modified organisms (GMOs), transgenic crops, and recombinant DNA technology are the future trends in plant biotechnology.
What are the implication of Biotechnology?
There have been a number of recent developments which have excited the implication of biotechnology.
On the other hand, it should be recognized that biotechnology has played a major role in the past, as well as the present, on various industrial sectors.
What Does The Future Hold?
Capital markets in the US will be more robust than in 2006, and biotech's elite companies will outperform the Dow Jones Industrial Average and the NASDAQ.
